Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation
Status:
Completed
Trial end date:
2016-08-02
Target enrollment:
Participant gender:
Summary
This study is being done to see if MORAb-004 increases the effectiveness of the
chemotherapies gemcitabine and docetaxel in people with metastatic Soft Tissue Sarcoma.